Home/Filings/4/0001209191-20-045297
4//SEC Filing

Helash Kevin 4

Accession 0001209191-20-045297

CIK 0001441693other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 7:17 PM ET

Size

11.0 KB

Accession

0001209191-20-045297

Insider Transaction Report

Form 4
Period: 2020-08-04
Helash Kevin
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-08-04+2,000,0002,000,000 total
    Exercise: $1.16Exp: 2030-08-04Common Stock (2,000,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-08-04+225,000225,000 total
    Exercise: $1.16Exp: 2030-08-04Common Stock (225,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-08-04+225,000225,000 total
    Exercise: $1.16Exp: 2030-08-04Common Stock (225,000 underlying)
Footnotes (3)
  • [F1]The shares subject to the option will vest with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 3, 2020 ("Vesting Commencement Date"), and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.
  • [F2]The shares subject to the option will vest fully upon the attainment of a certain closing price for the Company's stock, as quoted on the Nasdaq Stock Market, for 30 consecutive trading days, by that date which is 30 days following the reporting of financial results for the Company's second quarter of its fiscal year ending December 31, 2022, subject to optionee's continued employment.
  • [F3]The shares subject to the option will vest over a period of four years as measured from the Vesting Commencement Date, on a pro-rata basis equally each month, subject to acceleration on the date on which the Company files its Annual Report on Form 10-K for the fiscal year ending December 31, 2020 if, within such report, the Company reports the achievement of certain revenue, margin and expense performance targets for its 2020 fiscal year, each of which are within 10% of the Company's internal targets for the year with respect to the achievement of certain specified performance targets.

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

Entity typeother

Related Parties

1
  • filerCIK 0001818849

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:17 PM ET
Size
11.0 KB